EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urinary renal epithelial cells can be used for NPHP1 phenotyping and a personalized therapeutic strategy

Praveen Dhondurao Sudhindar, Eric Olinger iD, Zachary T Sentell iD, Holly Mabillard iD, Barbora Dicka, Katrina Wood, Dominic Rutland iD, Catherine Collins, Marco Trevisan-Herraz, John A Sayer iD, Juliana E Arcila-Galvis iD

Journal of Cell Science · 2025

DOI: 10.1242/jcs.264141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Science, 2025. Verfasst von Praveen Dhondurao Sudhindar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK. Hauptthemen laut MEDLINE: Epithelial Cells, Kidney Diseases, Cystic, Precision Medicine, Kidney. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon European Union, Medical Research Council, PKD Charity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nephronophthisis (NPHP) is a recessive tubulointerstitial nephropathy and a leading genetic cause of kidney failure in children and young adults. The most common genetic cause is a homozygous deletion of NPHP1, which encodes nephrocystin-1, a protein essential for primary cilium structure and cell junctions. Using personalized medicine and deep phenotyping, we investigated a family with three siblings carrying a homozygous NPHP1 deletion. We compared kidney biopsy tissue and human urine-derived renal epithelial cells (hURECs) from these individuals. Bulk RNA-seq on patient hURECs revealed altered expression in EGFR signalling, extracellular components and adherens junctions, which is consistent with the known roles for nephrocystin-1. Treatment with alprostadil, a proposed NPHP therapy, increased ciliation but worsened ciliary elongation. By contrast, the EGFR kinase inhibitor AG556 rescued of ciliary length and morphology. Transcriptional profiling post-treatment showed AG556 reversed the disease signature more effectively that alprostadil. These findings suggest that EGFR inhibition might offer a more promising therapeutic strategy for NPHP1-associated renal ciliopathy, warranting further testing in in vivo models before clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial CellsKidney Diseases, CysticPrecision MedicineKidneyAdaptor Proteins, Signal TransducingHumansPhenotypeMaleFemaleCiliaErbB ReceptorsAdultChildCytoskeletal Proteins

Stichwörter der Autor:innen

Adherens junctionsExtracellular matrixKidney failureNPHP1NephronophthisisPrecision medicinePrimary ciliaRNA-seqUrine-derived renal epithelial cellsWhole gene deletion

Substanzen

NPHP1 protein, humanErbB ReceptorsAdaptor Proteins, Signal TransducingCytoskeletal Proteins

Autor:innen und Institutionen

  • Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK.
  • Center for Human Genetics, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK.
  • Royal Victoria Infirmary, Newcastle upon Tyne, NE2 4LP, UK.
  • Renal Services, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, UK.
  • NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne, NE4 5PL, UK.

ORCID-Profile: Eric Olinger, Zachary T Sentell, Holly Mabillard, Dominic Rutland, John A Sayer, Juliana E Arcila-Galvis

Förderung

  • Horizon European Union
  • Medical Research Council
  • PKD Charity
  • Kidney Research UK
  • Northern Counties Kidney Research Fund
  • Newcastle University
  • LifeArc
  • Swiss National Science Foundation

Zitieren

APA

Sudhindar, P. D., Olinger, E., Sentell, Z. T., Mabillard, H., Dicka, B., Wood, K., Rutland, D., Collins, C., Trevisan-Herraz, M., Sayer, J. A., & Arcila-Galvis, J. E. (2025). Urinary renal epithelial cells can be used for NPHP1 phenotyping and a personalized therapeutic strategy. Journal of Cell Science. https://doi.org/10.1242/jcs.264141

Vancouver

Sudhindar PD, Olinger E, Sentell ZT, Mabillard H, Dicka B, Wood K, et al. Urinary renal epithelial cells can be used for NPHP1 phenotyping and a personalized therapeutic strategy. Journal of Cell Science. 2025. doi:10.1242/jcs.264141

BibTeX
@article{Sudhindar2025,
  author = {Sudhindar, Praveen Dhondurao and Olinger, Eric and Sentell, Zachary T and Mabillard, Holly and Dicka, Barbora and Wood, Katrina and Rutland, Dominic and Collins, Catherine and Trevisan-Herraz, Marco and Sayer, John A and Arcila-Galvis, Juliana E},
  title = {Urinary renal epithelial cells can be used for NPHP1 phenotyping and a personalized therapeutic strategy},
  journal = {Journal of Cell Science},
  year = {2025},
  doi = {10.1242/jcs.264141}
}
Kostenlos starten →